1. Home
  2. ABVC vs SNCR Comparison

ABVC vs SNCR Comparison

Compare ABVC & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVC
  • SNCR
  • Stock Information
  • Founded
  • ABVC 2015
  • SNCR 2000
  • Country
  • ABVC United States
  • SNCR United States
  • Employees
  • ABVC N/A
  • SNCR N/A
  • Industry
  • ABVC Biotechnology: Pharmaceutical Preparations
  • SNCR EDP Services
  • Sector
  • ABVC Health Care
  • SNCR Technology
  • Exchange
  • ABVC Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • ABVC 52.1M
  • SNCR 61.5M
  • IPO Year
  • ABVC N/A
  • SNCR 2006
  • Fundamental
  • Price
  • ABVC $2.84
  • SNCR $5.00
  • Analyst Decision
  • ABVC
  • SNCR Strong Buy
  • Analyst Count
  • ABVC 0
  • SNCR 1
  • Target Price
  • ABVC N/A
  • SNCR $13.00
  • AVG Volume (30 Days)
  • ABVC 70.7K
  • SNCR 95.4K
  • Earning Date
  • ABVC 11-03-2025
  • SNCR 11-04-2025
  • Dividend Yield
  • ABVC N/A
  • SNCR N/A
  • EPS Growth
  • ABVC N/A
  • SNCR N/A
  • EPS
  • ABVC N/A
  • SNCR N/A
  • Revenue
  • ABVC $797,916.00
  • SNCR $170,909,000.00
  • Revenue This Year
  • ABVC $735.18
  • SNCR $1.36
  • Revenue Next Year
  • ABVC N/A
  • SNCR $5.22
  • P/E Ratio
  • ABVC N/A
  • SNCR N/A
  • Revenue Growth
  • ABVC 56.52
  • SNCR 0.07
  • 52 Week Low
  • ABVC $0.40
  • SNCR $4.83
  • 52 Week High
  • ABVC $5.48
  • SNCR $12.85
  • Technical
  • Relative Strength Index (RSI)
  • ABVC 46.98
  • SNCR 40.88
  • Support Level
  • ABVC $2.75
  • SNCR $4.83
  • Resistance Level
  • ABVC $3.03
  • SNCR $5.77
  • Average True Range (ATR)
  • ABVC 0.15
  • SNCR 0.36
  • MACD
  • ABVC -0.01
  • SNCR 0.05
  • Stochastic Oscillator
  • ABVC 32.79
  • SNCR 20.21

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: